Clinical Trial Update: Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment [Phase 1]

View source ↗

Summary

Phase 1 study evaluating absorption, elimination and safety of 14C-labeled BTZ-043, a novel tuberculosis drug. The trial has completed and results have been pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• BTZ-043 (BTZ-043)

Snippet

Sponsor: Michael Hoelscher | Conditions: Tuberculosis, Tuberculosis, Pulmonary | Phase 1 | Status: COMPLETED | Results posted: 2024-12-05